Kim Min-young, CEO

AngioLab harnesses expertise in angiogenesis to promote health and well-being

A pioneer in angiogenesis biotech, AngioLab develops angiogenesis inhibitors for various therapeutic interventions, and is open to collaborations for technology transfer

Topic |   South Korea Business Report

TOP PICKS

Kim Min-young, CEO
READ FULL ARTICLE